Clinical characteristics, resource use, and diagnostic accuracy of natriuretic peptides in cancer patients presenting with acute dyspnea to the Emergency Department

Back

ESC Premium Access

Clinical characteristics, resource use, and diagnostic accuracy of natriuretic peptides in cancer patients presenting with acute dyspnea to the Emergency Department

Session: Cardiotoxicity and development of heart failure

Topic: Cardio-Oncology

Speaker: Doctor P. Lopez Ayala (Basel, CH)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Pedro Lopez Ayala

University Hospital Basel, Basel (Switzerland)

2 presentations

0 follower

7 more presentations in this session

Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab

Speaker: Doctor N. Espinola-Zavaleta (Mexico City, MX)

Low clinical utility of global longitudinal strain in a real-world breast cancer population

Speaker: Doctor L. Ruane (Brisbane, AU)

Does HFpEF represent a risk factor and a marker of cardiotoxicity in patients undergoing cancer treatment?

Speaker: Doctor B. von Kemp (Brussels, BE)

Angiotensin receptor-neprilysin inhibitor (Sacubitril/Valsartan) in cancer therapy-related cardiac dysfunction: real-world experience from a nurse-led cardio-oncology clinic

Speaker: Miss P. Reehal (London, GB)

miRNAs profile as a signature for cardiovascular disease in long-term breast cancer female survivors: a pilot study

Speaker: Doctor A. Greatti (Ferrara, IT)

Access the full session

Cardiotoxicity and development of heart failure

Speakers: Doctor P. Lopez Ayala, Doctor N. Espinola-Zavaleta, Doctor L. Ruane, Doctor B. von Kemp, Miss P. Reehal...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources